Research

TORONTO GLOBE AND MAIL                               Nov. 3, 2014
By Kelly Grant
Canada is spending another $30.5-million to fight Ebola, but Ottawa is still not answering pleas from international aid organizations for medical personnel to care for the ill in West Africa.

The bulk of the money announced on Monday – $23.5-million – will be spent on testing a Canadian vaccine and an experimental therapy, ZMapp, both of which were developed largely at the National Microbiology Lab in Winnipeg....

A lab technician at the National Microbiology Lab in Winnipeg, Manitoba November 3, 2014.
(LYLE STAFFORD/THE CANADIAN PRESS)

Canada has so far dispatched two mobile laboratories with rotating teams of scientists to rapidly diagnose or rule out Ebola in Sierra Leone.

But Ottawa has been reluctant to send medical staff to West Africa because the government cannot guarantee they could be airlifted out if they fall ill.

WALL STREET JOURNAL                             Nov 3, 2014

By Amy Dockser Marcus

In the search for answers about Ebola, researchers are starting to look at an unexpected group of people: parents of children who have the rare but fatal genetic disease Niemann-Pick Type C.

Blood and tissue samples from Hugh and Chris Hempel of Reno, Nev., whose children have a rare disease, may help in ongoing Ebola research. Hempel family

The intersection between research in Ebola and NPC disease was surprising, and came after two scientific papers were published in 2011 demonstrating that a protein made by the same gene related to NPC disease is essential for Ebola infection.

Ebola uses the so-called NPC1 protein made by the gene to get into the cell and replicate the virus.

Now, research suggests that the gene that causes NPC disease may also offer protection against Ebola.

Read complete story:
http://online.wsj.com/articles/researchers-study-ebola-link-to-gene-in-rare-disease-1414965218

Overview of what still needs to be learned about the Ebola virus

Research studies have suggested at least three potential paths through which the Ebola virus can invade tissues. Credit Photograph by the C.D.C. via Getty Images

THE NEW YORKER                                      Nov. 1, 2014

By Jerome Groopman

...there are still serious gaps in what we know about the biology of Ebola, and that ignorance inhibits us from preventing future outbreaks and reducing death rates that still exceed seventy per cent. We don’t know enough about the biology of Ebola to bring the outbreak under full control, or to neutralize the virus once the outbreak is contained. Between on-the-ground efforts and advances in science, we need a balanced approach.

Read complete article

Scientists know a lot about the virus that causes Ebola — but there are many puzzles that they have yet to solve.

NATURE SCIENCE International Weekly Journal of Science                                   Oct. 29, 2014

To much of the world, the virus behind the devastating Ebola outbreak in Africa seems to have stormed out of nowhere. But Leslie Lobel thinks we should have seen it coming.

In 2012, Lobel and a team of researchers spent six months in Uganda studying the Ebola virus and related viruses. Over the course of their stay, these pathogens caused at least four separate outbreaks of disease in central Africa, affecting more than 100 people. To Lobel, a virologist at Ben-Gurion University of the Negev in Beer-Sheva, Israel, the outbreaks felt like the small tremors that can precede a major earthquake. “We all said, something is going on here; something big is going to happen,” he says.